ResApp

By Laura Lovett April 12, 2018
Brisbane, Australia-based ResApp Health, a digital health company that specializes in diagnosing respiratory diseases, is now conducting clinical proof-of-concept studies for its latest technology that uses a smartphone to detects sleep apnea by sound. Preliminary results from a clinical trial released by ResApp found that the technology achieved an 86 percent sensitivity and 83 percent...
By Jonah Comstock December 19, 2017
Brisbane, Australia-based ResApp is planning to re-do its big US trial soon, but in the meantime the smartphone respiratory diagnosis company is continuing to collect data in its native country. The company released data yesterday from a clinical study of more than 1,300 adult patients at Joondalup Health Campus in Perth and Wesley Hospital in Brisbane. While the company’s previous studies have...
By Jonah Comstock November 21, 2017
Brisbane, Australia-based ResApp intended to have its software, which uses a smartphone microphone to diagnose respiratory conditions based on coughs, well on its way through the FDA by now. But this past summer, the company’s big plans hit a major setback when the data came back from its landmark clinical trial, conducted at such austere institutions as Massachusetts General Hospital, Cleveland...
By Jonah Comstock August 30, 2017
Outcome Health, which equips providers with screens displaying educational content, has added its first chief engineering officer to its ranks. Nandini Ramani, who most recently served as VP of Engineering at Twitter, will assume the post. "Healthcare is an industry close to my heart and Outcome Health's impact on society is tangible and meaningful," Ramani said in a statement. "In addition to...
By Jonah Comstock August 9, 2017
Brisbane, Australia-based digital health company ResApp has been talking up its Smartcough-C study — a multisite, double-blind study of the company’s smartphone-based respiratory analysis software — for a number of months. Conducted at Massachusetts General Hospital, Cleveland Clinic, and Texas Children’s Hospital, the trial was intended to support ResApp’s FDA submission for a number of...
By Heather Mack May 12, 2017
Virtual medical assistant company Sensely is collaborating with the Mayo Clinic to ascertain how to leverage patient engagement and chronic disease monitoring technology. The partnership will blend the Mayo Clinic’s triage algorithms and clinical expertise with Sensely’s patient engagement platform in hopes of assessing and predicting which resources can be best used at the right time to help...
By Heather Mack May 9, 2017
International medical organization Doctors Without Borders (Médecins sans Frontières, or MSF) is looking to evaluate the use of an app to diagnose and manage respiratory disease in rural, low-income settings. An unofficial collaboration is already in the works with Australian digital health company ResApp, whom MSF has indicated they are interested in working with in a clinical study. ResApp,...
By Jonah Comstock April 26, 2017
DarioHealth launches in the UK. Israel-based DarioHealth, makers of a smartphone-connected glucometer, announced the launch of a direct-to-consumer channel in the United Kingdom. It is already available D2C in the US and Australia, but was previously available in the UK only through pharmacies and diabetes educators. PlushCare launches telemedicine EMR. PlushCare, a D2C telemedicine service...
By Jonah Comstock November 16, 2016
ResApp has announced the final site and received the final IRB approval for its Smartcough-C trial. Texas Children's Hospital will join the previously announced Massachusetts General Hospital and Cleveland Clinic in a three-site trial of the Australian company's ResAppDx app, which essentially uses the smartphone microphone as a stethoscope to listen to a patient’s breathing. The double-blind...
By Jonah Comstock October 24, 2016
ResApp, an Australian company developing an app to diagnose respiratory conditions based on cough sounds, has secured the first of three IRB approvals for its upcoming Smartcough-C pediatric trial, which will take place at the Cleveland Clinic, Massachusetts General Hospital, and a third site yet to be announced. ResApp’s offering — an app called ResAppDx — essentially uses the smartphone...